Photo credit: Carmen Yahchouchi/MSF
Open letter to Sanofi on barriers to accessing diabetes medicines
MSF sent this open letter to the CEO of pharmaceutical corporation Sanofi to urge action for greater access to insulin for people living with diabetes in humanitarian and resource-poor settings.
UPDATE, 11 November 2024: Sanofi responded on 10 October 2024 with this reply letter, which we have marked up with our comments.